Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.49B |
| 2 |
Alcon
ALC
|
+$805M |
| 3 |
Bank of America
BAC
|
+$662M |
| 4 |
RTN
Raytheon Company
RTN
|
+$621M |
| 5 |
Dow Inc
DOW
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.18B |
| 2 |
Wells Fargo
WFC
|
+$1.01B |
| 3 |
Qualcomm
QCOM
|
+$860M |
| 4 |
American Tower
AMT
|
+$688M |
| 5 |
Alibaba
BABA
|
+$651M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.08% |
| 2 | Financials | 14.73% |
| 3 | Technology | 14.09% |
| 4 | Industrials | 10.91% |
| 5 | Consumer Discretionary | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Luxfer Holdings
LXFR
$456M
| $79.6M | 0.02% |
3,244,408
-160,960
| -5% | -$3.91M |
|
627
Trip.com Group
TCOM
$29.6B
| $79.3M | 0.02% |
2,148,342
+469,279
| +28% | +$18.5M |
|
628
MGM Resorts International
MGM
$11.4B
| $79.3M | 0.02% |
2,775,208
-55,485
| -2% | -$1.48M |
|
629
EXL Service
EXLS
$5.14B
| $78.7M | 0.02% |
5,948,670
+49,810
| +0.8% | +$611K |
|
630
Diageo
DEO
$49B
| $78.1M | 0.02% |
453,429
-12,948
| -3% | -$2.18M |
|
|
ODT
631
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $77.4M | 0.02% |
+2,108,918
| New | +$50.5M |
|
632
New Jersey Resources
NJR
$5.84B
| $77.3M | 0.02% |
1,552,152
+7,252
| +0.5% | +$357K |
|
633
Avantor
AVTR
$9.32B
| $77.2M | 0.02% |
+4,046,546
| New | +$72M |
|
634
Credicorp
BAP
$31.8B
| $77.2M | 0.02% |
337,136
-59,599
| -15% | -$13.7M |
|
635
Altria Group
MO
$114B
| $76.9M | 0.02% |
1,623,889
+21,927
| +1% | +$1.15M |
|
|
HMHC
636
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $76.8M | 0.02% |
13,326,296
+2,329,516
| +21% | +$15.5M |
|
|
NP
637
DELISTED
Neenah, Inc. Common Stock
NP
| $76.7M | 0.02% |
1,135,029
+134,200
| +13% | +$8.47M |
|
|
CSII
638
DELISTED
Cardiovascular Systems, Inc.
CSII
| $76.6M | 0.02% |
1,785,013
-110,568
| -6% | -$4.29M |
|
639
Tyler Technologies
TYL
$12.7B
| $76.6M | 0.02% |
+354,534
| New | +$76.9M |
|
640
Euronet Worldwide
EEFT
$2.72B
| $76.2M | 0.02% |
452,630
+111,666
| +33% | +$17.1M |
|
641
AtriCure
ATRC
$1.92B
| $75.8M | 0.02% |
2,539,967
-62,468
| -2% | -$1.82M |
|
642
Spectrum Brands
SPB
$2.04B
| $75.1M | 0.02% |
1,397,572
+11,521
| +0.8% | +$685K |
|
643
KKR & Co
KKR
$91.1B
| $75M | 0.02% |
2,969,340
-1,104,576
| -27% | -$26.4M |
|
|
LTHM
644
DELISTED
Livent Corporation
LTHM
| $74.8M | 0.02% |
10,814,712
+1,665,760
| +18% | +$15M |
|
|
CLR
645
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $74.6M | 0.02% |
1,771,705
+49,808
| +3% | +$2.13M |
|
|
RVNC
646
DELISTED
Revance Therapeutics, Inc.
RVNC
| $74M | 0.02% |
5,703,467
-40,667
| -0.7% | -$513K |
|
647
Wingstop
WING
$3.53B
| $74M | 0.02% |
780,657
-167,668
| -18% | -$13.7M |
|
648
Xcel Energy
XEL
$48.8B
| $73.7M | 0.02% |
1,238,732
-2,201,859
| -64% | -$127M |
|
|
NVTA
649
DELISTED
Invitae Corporation
NVTA
| $72.9M | 0.02% |
3,101,036
-928,003
| -23% | -$19.8M |
|
|
ARRY
650
DELISTED
Array Biopharma Inc
ARRY
| $72.7M | 0.02% |
1,569,465
+516,390
| +49% | +$14.5M |
|
Similar funds
Wellington Management Group's Q2 2019 Portfolio in Review
As of Q2 2019, Wellington Management Group held 2,200 positions worth $452B, up 2.3% from $442B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wellington Management Group's Q2 2019 filing shows 165 new, 807 increased, 919 reduced and 161 closed positions. Its largest new stake was Alcon: 13,706,926 shares worth $848M. The largest sale was DuPont de Nemours, an estimated $1.18B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q2 2019 buy was Alcon: 13,706,926 shares worth $848M.
- Wellington Management Group added most to Pfizer in Q2 2019, an estimated $2.49B increase.
- Wellington Management Group's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $1.18B.
- Wellington Management Group fully exited Zillow in Q2 2019, selling an estimated $189M.
- Wellington Management Group's ten largest holdings make up 15% of its $452B portfolio in Q2 2019.
- Wellington Management Group opened 165 new positions and closed 161 in Q2 2019.
- Wellington Management Group's portfolio value rose 2.3% quarter-over-quarter to $452B.
Based on Wellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.